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In a normal stratified squamous epithelium, β1-integrin is expressed in basal epithelial cells. In BPV-induced fibropapillomas β1-integrin is
overexpressed and aberrantly localized, with uniform expression in the lower spinous layer, and sporadic expression within the mid-spinous region
that co-localizes with expression of the viral E5 and E7 oncoproteins. In situ hybridization of fibropapillomas for β1-integrin RNA revealed
sporadic hybridization in the spinous layer, indicating transcriptional induction. β1-integrin expression in cultured keratinocytes requires
exogenous EGF in the media, but this requirement is lost if E7 is expressed, and E7 was able to abrogate the EGF-requirement of normal
keratinocytes for the activation of ERK and DNA synthesis. Within fibropapillomas, suprabasal expression of E5 and E7 correlated with
suprabasal expression of β1-integrin and PCNA, indicating that vegetative viral replication in the spinous layer correlated with the expression of
E7 and β1 integrin. The ability of BPV-1 E7 to support β1-integrin expression and EGF independent DNA synthesis and the activation of ERK
are the first biochemical correlates of its expression in keratinocytes.
© 2006 Elsevier Inc. All rights reserved.Keywords: Integrin; Oncoprotein; PsoriasisIntroduction
Papillomaviruses induce squamous epithelial neoplasms in
vertebrates. Virus-induced papillomas are benign lesions
containing low copy numbers of episomal viral DNA in
proliferative basal epithelial cells. In the spinous layer of the
papilloma, a subset of cells re-enter the cell cycle and amplify
viral DNAs to high copy number in a process termed vegetative
viral DNA replication (reviewed in Chow and Broker (1994);
Stubenrauch and Laimins (1999)). As cells with amplified viral
DNA copy number move higher within the stratified epithe-
lium, a subset of cells express late gene capsid proteins in the
granular cell layer, encapsidate viral DNA and are finally shed
from the surface of the papilloma as desquamated epithelial
cells containing infectious virus. This is unlike normal
squamous epithelium where cells divide in the basal layer,
move into the spinous cell layer, but then commit to a terminal
differentiation pathway.⁎ Corresponding author. Fax: +1 434 924 1545.
E-mail address: vandepol@virginia.edu (S.B. Vande Pol).
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effect the re-entry of spinous cells into the cell cycle is best
understood in the case of the human papillomaviruses (HPV)
that are associated with cervical cancer (HPV-16) (reviewed in
Munger et al. (2001)). In this system, the expression of the
HPV-16 E7 oncoprotein is necessary and sufficient for cultured
keratinocytes in vitro to aberrantly re-enter the cell cycle upon
detachment of the keratinocytes from a tissue culture plate
(Flores et al., 2000). HPV-16 E7 (16E7) induction of vegetative
viral DNA amplification is associated with the ability of E7 to
interact with and degrade members of the retinoblastoma family
of tumor suppressors. While only E7 proteins of the cancer-
associated HPV types target the degradation of the retinoblas-
toma protein, all HPV E7 genes contain an interaction motif
(termed LXCXE) for the retinoblastoma family of proteins, and
therefore are presumed to effect spinous layer cell cycle re-entry
through interactions at the LXCXE motif (Munger et al., 2001).
Consistent with this theory, expression of both “high risk” and
“low risk” HPV E7 proteins results in the activation of E2F
transcription factors, thereby inducing limiting factors required
for S phase such as thymidine kinase, dehydrofolate reductase,
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kinase inhibitors (CKIs) p21 Cip1 and p27 Kip1, thereby further
promoting the ability of spinous layer cells to re-enter the cell
cycle (Jones and Munger, 1997). However, it seems unlikely
that the same mechanisms are utilized by BPV-1 to effect
spinous layer viral replication. There is only limited sequence
similarity in the amino terminus of 16E7 and BPV-1 E7; BPV-1
E7 does not have a LXCXE interaction motif for the
retinoblastoma family of tumor suppressors that is found in
all HPV E7 oncoproteins. While HPV E7 proteins interact with
the retinoblastoma protein in vitro, BPV-1 E7 does not (Munger
et al., 1989), nor does BPV-1 E7 exhibit either the ability to
transactivate E2F responsive promoters or abrogate Rb induced
cell cycle arrest in vivo (our unpublished observations).
However, there is circumstantial evidence that BPV-1 E7
might contribute to viral amplification in the spinous layer:
BPV-1 E7 does not have a strong independent transforming
activity, but it cooperates in transformation assays with both the
BPV-1 E5 and E6 oncogenes, and is expressed in the cytoplasm
and nucleus of the spinous layer where BPV-1 vegetative viral
amplification is known to occur (Bohl et al., 2001).
So if BPV-1 E7 does not act directly upon members of the
retinoblastoma family to effect cell cycle re-entry in the spinous
layer, how does the coordinated expression of BPV-1
oncoproteins accomplish this? Experiments in mouse embryo
fibroblasts have demonstrated that in the absence of retino-
blastoma family members, G1/S checkpoint control is lost (Sage
et al., 2000), and that retinoblastoma inactivation normally
occurs through the sequential activity of cyclin dependent
kinases (Jacks and Weinberg, 1998). Signals generated by
soluble growth factors, and integrins interacting with insoluble
matrix molecules induces cyclins and thereby cyclin dependent
kinase activity. In normal fibroblasts, matrix attachment
throughout early G1 phase is required for cell cycle progression,
and ectopic expression of cyclin D and an activated cdk4 can
replace SV40 T-antigen or HPV-16 E7 protein to support
anchorage independent cell growth (Hahn et al., 2002). The
known properties of BPV oncoproteins suggest the possibility
that signal transduction initiated by these oncoproteins controls
spinous cell viral DNA replication.
In normal keratinocytes, both soluble growth factors and
contact with an extracellular matrix-coated surface and signal-
ing through integrin receptors is required for cell proliferation.
Integrins are a large and diverse family of heterodimeric
receptors (associated alpha and beta chains) for extracellular
matrix molecules such as collagen, laminin, and fibronectin that
generate both survival and proliferative signals for keratino-
cytes (reviewed in Giancotti and Ruoslahti (1999); Watt
(2002)). The integrin receptor chain most closely associated
with keratinocyte proliferation is β1-integrin that is associated
principally with α2 and α3 chains, but also associated to a lesser
extent with α1, α5 and αv during wounding or in vitro culture.
Upon detachment from a matrix coated surface, normal
keratinocytes commit to a terminal differentiation program
(Green, 1977) characterized by the rapid loss of β1-integrin and
the induced expression of the keratinocyte differentiation
marker involucrin that is found in spinous layer keratinocytes;if integrin receptors are engaged through stimulating antibodies,
suspension-induced differentiation is repressed (Watt et al.,
1993). In addition, upon wounding of a squamous epithelium,
β1-integrin is induced, and suprabasal expression is observed
together with immature matrix deposition until closure and
maturation of the wound is complete (Breitkreutz et al., 1997;
Hertle et al., 1992; Juhasz et al., 1993).
The BPV-1 E5 oncoprotein has been shown to provide
signals similar to those elicited by soluble growth factors. E5
interacts with the PDGF and EGF receptors to stimulate ligand-
independent intracellular activation of the receptor (Cohen et
al., 1993; Petti et al., 1991). BPV-1 E5 also modulates EGF
receptor downregulation (Cohen et al., 1993; Martin et al.,
1989), resulting in enhanced expression of ligand-occupied
EGF receptor. It is as yet uncertain if E5 transformation is
exclusively through activation of receptor tyrosine kinases or if
additional BPV-1 E5 activities contribute. BPV-1 E5 interacts
with a 16 kDa vacuolar ATPase (Goldstein et al., 1991)
resulting in the alkalization of intracellular compartments,
which may contribute to its transforming ability (Oelze et al.,
1995; Schapiro et al., 2000, Sparkowski et al., 1995, 1996;
Straight et al., 1995).
The BPV-1 E6 (BE6) protein can interact with the cellular
proteins E6AP, paxillin and the AP-1 adaptin complex (Tong
and Howley, 1997; Tong et al., 1998; Vande Pol et al., 1998).
The interaction of BE6 with paxillin is correlated with
transformation by BE6 (Das et al., 2000). BE6 binds to E6AP
and paxillin through interaction with homologous peptide
sequences found on the target proteins (Chen et al., 1998; Elston
et al., 1998; Vande Pol et al., 1998), and transformation by E6
can be repressed by competitive binding of E6 to homologous
peptides that interact with E6 (Bohl et al., 2000).
Because paxillin is required for early integrin signaling
events such as the tyrosine phosphorylation of Focal Adhesion
Kinase and remodeling of the actin cytoskeleton after cell
attachment (Wade et al., 2002), we examined BPV-induced
fibropapillomas for the expression of focal adhesion proteins.
We found that there is a large elevation in paxillin and β1-
integrin expression in virally infected epithelium compared to
normal-appearing surrounding skin. Surprisingly BPV-1 E7 can
supplant the requirement of EGF for the expression of β1-
integrin, the activation-associated phosphorylation of ERK, and
DNA synthesis by keratinocytes.
Results
Our prior studies that examined the interaction of BPV-1
E6 with paxillin induced us to examine bovine fibropapillo-
mas for the expression of paxillin and paxillin-associated
proteins including β1 integrin. In order to better appreciate the
differences between normal skin and fibropapillomas and the
localization of β1 integrin, Fig. 1A shows a hematoxylin and
eosin stained bovine fibropapilloma at low magnification. The
left portion of Fig. 1A demonstrates the marked epithelial
hyperplasia and the displacement of the normal dermis by the
virally-induced dermal fibroma. Figs. 1B and C illustrate that
the epithelial hyperplasia in the fibropapilloma arises from a
Fig. 1. Histology of bovine fibropapillomas. Paraffin embedded sections of bovine fibropapillomas were stained with hematoxylin and eosin. (A) Low power shows a
fibropapilloma on the left side with epithelial hyperplasia and replacement of normal dermal hair follicles and sweat glands by virus induced dermal fibroma. The right
portion shows adjacent normal bovine skin with a 3–4-cell layer epidermis and normal underlying dermis with mature collagen and penetrating circular hair follicles
and sweat glands. (B) Medium power view of normal epithelium adjacent to fibropapilloma. (C) Fibropapilloma shown at same power as panel B, showing epithelial
hyperplasia and replacement of normal dermal structures by fibroma. (D) Fibropapilloma showing the dermal–epidermal junction and overlying dermis. Arrows mark
small spinous layer cells with dense staining cytoplasm, and arrowheads illustrate large spinous layer cells with large nuclei and pale staining cytoplasm.
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and illustrates the location of the basal (marked b), spinous
(marked s) and granular cell layers (marked g) in Fig. 1C.
Spinous cells in normal skin have a uniform eosinophillic
cytoplasm, while in the fibropapilloma, these cells are
admixed alone and in small groups with cells that have pale
cytoplasm and enlarged nuclei; in the upper spinous layer,
these cells sporadically contain vacuolated cytoplasm char-
acteristic of koilocytes (Figs. 1C and D) (Boon and Fox,
1981; Casas-Cordero et al., 1981; Ferenczy et al., 1981;
Komorowski and Clowry, 1976; Pilotti et al., 1981).
The upper 2 panels of Fig. 2A illustrate β1 integrin
expression in normal bovine skin adjacent to a fibropapilloma,
and the lower 2 panels show fibropapilloma. In normal skin,
cells in the spinous layer and above do not stain for β1 integrin.
Basal cell staining intensity is lower than that of dermal blood
vessels indicated with arrows. In contrast, the lower 2 panels
show the same tissue section and the same duration exposure for
the basal region of the adjacent fibropapilloma. In the
fibropapilloma, basal expression of β1 integrin was more
intense than that of normal skin or the underlying dermal blood
vessels. β1 integrin staining extended fully onto the apical
surface of basal cells and was intense into the first 3 cell layers
of the lower spinous region. Clearly positive β1 integrin
staining extended into the mid-spinous region in a sporadic way
and at a level exceeding that of basal cells in adjacent normal
skin; those cells had larger nuclei and less fibrous cytoplasmthan surrounding spinous layer cells, similar to the cells with
enlarged nuclei and pale cytoplasm illustrated in Fig. 1.
Fluorescence pixel intensity of β1-integrin expressions was
assessed using image analysis software of equivalent exposures
of normal skin and fibropapilloma from the same tissue section.
Dermal blood vessels in fibropapilloma were slightly elevated
in β1 integrin pixel intensity compared to dermal blood vessels
in normal adjacent skin (ratio of 1.2). In normal skin the ratio of
basal epithelium to blood vessel pixel intensity for β1 integrin
was 0.3 averaged over 5 locations. In fibropapillomas the ratio
of β1 integrin pixel intensity of basal epithelium to underlying
dermal blood vessels was 1.35.
Integrin beta chains are paired with alpha chains to make a
complete matrix receptor. We examined bovine skin and adjacent
fibropapillomas for the expression of alpha 2, 3, and 5 chains.
α2β1 and α3β1 are the major basal cell integrins in normal skin
and are receptors for collagen and laminin 5 respectively. α5β1
(fibronectin receptor) and αvβ1 are not observed in normal
human skin but are observed in wounded skin and in cultured
keratinocytes (Hertle et al., 1992; Juhasz et al., 1993). Fig. 2B
shows that α3 and β1 co-localize in both normal bovine skin and
adjacent fibropapilloma. Antibodies to α2 were technically less
satisfactory but stained in a similar fashion as α3 (data not
shown). Fig. 2C shows that antibodies to α5 stained the fibroma
but did not stain the epithelioma portion of the fibropapilloma,
nor stained normal adjacent skin. In this regard, BPV induced
fibropapillomas differ from previous reports on the induction of
Fig. 2. β1 integrin is overexpressed and aberrantly localized in bovine fibropapillomas. (A) Dapi stained normal epithelium adjacent to a fibropapilloma is illustrated
with the location of the dermal–epidermal border indicated by arrowheads, and a dermal blood vessel indicated by small arrows. The adjacent panel stained with
antibody AIIB2 directed to β1 integrin (as indicated in the figure) is shown, with arrowheads and arrows indicating the dermal–epidermal junction and dermal blood
vessel as in the dapi-stained panel. β1 integrin is only observed in basal epithelium, and is expressed at lower levels than the underlying dermal blood vessel. In the left-
lower panel, a dapi stained section of bovine fibropapilloma is shown with arrowheads and arrows, and the same section is stained with antibody to β1 integrin as
indicated in the lower right panel. Expression of β1 integrin in the suprabasal epidermis exceeds that of dermal blood vessels, and scattered epidermal cells stain
positive for β1 integrin in the lower to mid spinous region. (B) Expression of α3 integrin in fibropapilloma. The same tissue section is co-localized for expression of α3
and β1 integrin as illustrated. The left panel nuclei are stained with dapi. (C) Expression of α5 integrin in fibropapilloma. The same tissue section is co-localized for
expression of α5 and β1 integrin as illustrated. The left panel nuclei were stained with dapi.
105B. Cooper et al. / Virology 355 (2006) 102–114α5 upon wounding of skin (Hertle et al., 1992; Juhasz et al.,
1993), and indicate that the induction of β1-integrin is not a non-
specific wounding response in the epithelioma.The distribution of β1 integrin in the fibropapilloma was
reminiscent of the distribution of BPV-1 E7, where basal
expression of E7 extends uniformly into the lower spinous layer
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In order to determine if the overexpression of β1 integrin in the
spinous layer of fibropapillomas correlated with the expression
of a particular BPV oncoprotein, E7, E5, and β1 integrin were
co-localized using rabbit antibodies to E5 and E7, and rat anti-
β1-integrin. Figs. 3A and B demonstrate that rabbit antibody
directed against E5 or E7 respectively did not react against
normal bovine skin, while Figs. 3C and D show extensive co-
localization of both E5 and E7 with β1 integrin. While all β1
integrin positive cells in the spinous layer also expressed E5,
some beta1-integrin positive cells in the spinous layer were
detected where E7 expression was not obvious. This most likely
reflects the great difficulty of detecting E7 protein by indirect
immune fluorescence, since we have shown that E7 expression
can have a phenotypic transformation consequence in the
absence of observable protein expression (Bohl et al., 2001).
Despite high titered antiserum to BPV-1 E6, we have been
unable to localize this protein in fibropapillomas. The same
pattern of expression of β1 integrin in fibropapillomas was also
observed for the integrin-associated adapter protein paxillin
(Fig. 4). Paxillin is an adapter protein that associates with BPV-
1 E6, is required for the activating tyrosine phosphorylation of
Focal Adhesion Kinase (FAK) in embryonic stem cells, and is a
critical transducer of integrin signaling (Tong and Howley,
1997; Vande Pol et al., 1998; Wade and Vande Pol, 2006; Wade
et al., 2002). Fig. 4 demonstrates that paxillin is overexpressed
in the basal region of fibropapillomas compared to adjacent
normal skin. Higher-powered examination of fibropapilloma
and normal skin from the same tissue section demonstrates
clearly enhanced expression in basal and parabasal cells as well
as scattered supra-basal expression as observed in staining of β1
integrin. Paxillin staining co-localized with E7 and E5 staining
in both the basal and spinous region as was observed in Fig. 3
for the co-localization of E5, E7, and β1 integrin (data not
shown). Examination of fibropapillomas for the focal adhesion
protein talin showed a similar pattern of over-expression and
aberrant localization to the spinous layer as observed for β1
integrin and paxillin (data not shown). Thus in BPV-1
fibropapillomas, there is aberrant overexpression and mis-
localization of a set of focal adhesion proteins that are normally
restricted to the basal layer of squamous epithelium.
In order to determine if expression of β1-integrin protein in
the spinous layer of productive bovine warts correlated with
enhanced transcription of β1-integrin RNA, in situ hybridiza-
tion of BPV-1 fibropapillomas was performed using sense and
anti-sense probes to β1-integrin and actin. Silver grains
resulting from hybridized sense probes to actin hybridized
uniformly to the basal and parabasal epithelium, but at an
overall reduced level in the spinous layer (Fig. 5). However,
scattered cells in the mid-spinous layer that had enlargedFig. 3. Elevated β1 integrin expression correlates with expression of E7 and E5 in fi
fibropapilloma. Arrowheads indicate dermal–epidermal junction and arrows dermal
underlying dermal blood vessels. (B) Antiserum to E7 fails to stain normal epithelium
arrows dermal blood vessels. Low level staining for β1 integrin is less than that obser
in fibropapillomas. Fibropapilloma from the same tissue section as shown in panel A
with the same exposure as in panel A. (D) Co-expression of E7 and β1 integrin in fib
was co-immunostained with mouse monoclonal antibody to β1 integrin and rabbit ponuclei and less dense cytoplasm (similar in appearance to cells
illustrated in Fig. 1D) had about 4 fold more silver grains than
adjacent cells with smaller nuclei and dense cytoplasm,
indicating that these cells were transcriptionally more active
for the actin housekeeping gene. Surprisingly, spinous cells
with enlarged nuclei and light-staining cytoplasm were
somewhat more active for actin transcription than underlying
basal cells (25.4±4.1 grains/cell versus 14.7±2.3 grains/cell),
while the smaller uniform-sized spinous cells were reduced in
actin transcription (6.8±0.6 grains/cell). β1-integrin transcrip-
tion showed a similar pattern to actin transcription . Spinous
layer cells with enlarged nuclei and less dense cytoplasm had
5.3±1.7 grains per cell compared to 1.0±0.45 grains per cell
for spinous layer cells with small regular nuclei and dense
cytoplasm, and 2.2±0.4 grains per cell for basal and parabasal
cells. As was observed for actin, the dermal fibroma had the
highest levels of β1-integrin transcription at 6.4 grains per
cell.
In order to determine if the expression of the E5, E7, or both
oncoproteins induced overexpression of β1 integrin, we
retrovirally transduced immortalized human keratinocytes
(NIKS cells) with either empty vectors or separate retroviruses
expressing E5 and E7. NIKS cells are spontaneously immorta-
lized and near diploid, but are otherwise phenotypically normal,
generate normal appearing squamous epithelium, support the
full HPV papillomavirus life cycle, and are dependent upon
feeder cells, insulin, and EGF for continuous proliferation
(Allen-Hoffmann et al., 2000). To our surprise, in several
experiments no difference in β1 integrin expression was
observed between vector transduced and E5+E7 transduced
NIKS cells (data not shown). We speculated that since the
standard culture conditions were optimized for maximal cell
proliferation on plastic plates, and that maximal cell prolifera-
tion is rarely observed in vivo even in papillomas, that the effect
of E5 and E7 might only be revealed under less than maximal
growth stimulating conditions. Fig. 6A shows in the upper panel
that the expression of slower migrating broad β1 integrin form
requires EGF addition to the media while insulin was not
required. In the lower panel of Fig. 6A, NIKS cells transduced
with both E5 and E7 no longer require exogenous EGF to
maintain expression of β1integrin. In experiments not shown
here, the upper broad β1-integrin band from β1-integrin
immune precipitates could be reduced to the migration of the
lower band by treatment with PGNase indicating that the upper
band is glycosylated.
In order to determine if both E5 and E7 were required to
support the expression of β1-integrin in the absence of EGF,
NIKS cells separately transduced with either empty vector, E5,
or E7 were tested for the ability to express β1-integrin in the
absence of added EGF. Fig. 6B shows one representativebropapillomas. (A) Antiserum to E5 fails to stain normal epithelium adjacent to
blood vessels. Low level staining for beta1 integrin is less than that observed in
adjacent to fibropapilloma. Arrowheads indicate dermal–epidermal junction and
ved in underlying dermal blood vessels. (C) Co-expression of E5 and β1 integrin
was co-immunostained with antibody to β1 integrin and E5 and photographed
ropapillomas. Fibropapilloma from the same tissue section as shown in panel B
lyclonal antibody to E7 and photographed with the same exposure as in panel B.
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integrin expression in the absence of exogenous EGF than did
E5 (Fig. 6B).In order to determine if the effect of the E7 gene upon β1-
integrin expression was due to the expression of the E7 protein, a
zinc finger was ablated by in-frame deletion of a cysteine (E7
Fig. 4. Expression of paxillin in bovine fibropapillomas. The upper panel shows a 40× view of a bovine fibropapilloma and adjacent normal skin on the left side
(margin indicated by an arrowhead). The lower left panel (normal skin) and lower right panel (fibropapilloma) are 400× views taken from the same stained
section as shown in the upper 40× panel. Arrows indicate lymphocytes in the normal skin (lower left), and arrow heads spinous epithelial cells in the
fibropapilloma that overexpress paxillin (lower right). Detection is by peroxidase coupled secondary antibody developed with di-aminobenzoate and counter-
stained with hematoxylin.
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expression of β1-integrin in the absence of exogenous EGF was
ablated upon deletion of cysteine 118, indicating that expression
of wild type E7 protein and not another product from the E7 open
reading frame is required to support β1-integrin expression.
Since E7 reduced the EGF requirement of NIKS cells for the
expression of glycosylated β1 integrin, we sought to determine
if E7 could alter signal transduction in the absence of EGF.
Experiments examining the effect of E7 upon the abundance
and phosphorylation of the EGF receptor gave inconsistent
results, and we saw no consistent difference in Focal Adhesion
Kinase (FAK) phosphorylation (data not shown), a non-receptor
tyrosine kinase downstream of integrin signaling. However,
keratinocytes also express PYK2, a non-receptor tyrosine
kinase closely related to FAK, that can be activated by integrin
signaling as well as diverse stimuli that increase intracellular
calcium levels (Avraham et al., 2000). PYK2 has been shown to
be differentially regulated from FAK during epithelial to
mesenchymal transitions (Nakamura et al., 2001), but can
activate ERK through a GRB2-SOS dependent mechanism
(Blaukat et al., 1999). Fig. 7A demonstrates that E7 was able to
support the tyrosine phosphorylation of PYK2 in the absence of
EGF, and correlating with this, was able to support the
activating phosphorylation of ERK in the absence of EGF
(Fig. 7B).
Since NIKS cells require EGF for optimal proliferation, we
determined if E7 could reduce the requirement of NIKS cellsfor EGF to synthesize DNA. NIKS cells were plated onto
fibronectin-coated plastic and placed into media containing
0.25% FBS, insulin, but no added EGF. After 48 h, the media
was supplemented with BrdU for 36 h. In the absence of added
EGF, only 14% of vector transduced NIKS cell nuclei were
BrdU positive, while 53% of E7 transduced NIKS cells were
BrdU positive (Fig. 8A). In the presence of EGF, (Fig. 8A,
black bars) both cell lines were similar in DNA synthesis.
Mutation of either zinc finger (E7 Δ118 or E7 C82A) or
deletion of amino acids 21–23 of E7 abrogated the effect of
E7. As expected, Fig. 8A shows that E5 alone could also
promote S phase entry of NIKS cells in the absence of
exogenously added EGF.
The sporadic expression of E7, E5, and β1-integrin in the
mid-spinous layer of fibropapillomas resembles the pattern of
localization of spinous cells that amplify viral DNA in the
mid-spinous layer (Barksdale and Baker, 1993). In order to
determine if E5 and E7 positive cells in the spinous layer also
are permissive for DNA replication, fibropapillomas were
stained for E7 and proliferating cell nuclear antigen (PCNA).
Fig. 8B demonstrates that all PCNA positive cells in the
spinous layer also express E7. Similar results were obtained
upon staining for E5 and PCNA (data not shown). We were
unable to stain for both β1-integrin and PCNA simulta-
neously as β1-integrin detection requires native protein and
PCNA detection requires denatured protein, but the high co-
incidence of E7 and β1-integrin expression (Fig. 3D) assures
Fig. 5. Detection of β1 integrin RNA in fibropapillomas. β1 integrin and β-actin were detected by in situ hybridization as described in Materials and methods. (A)
Brightfield photograph of a bovine fibropapilloma hybridized to actin probe. (B) Darkfield photograph of the same field as shown in panel A. (C) Brightfield
photograph of bovine fibropapilloma hybridized to a β1 integrin probe. (D) Darkfield photograph of the same field as shown in panel C. To innumerate grains of silver
per cell, multiple photographs were taken from a single tissue section in both brightfield and darkfield illumination. 300 cells of each type (basal, spinous cells with
large nuclei and light-stained cytoplasm, spinous cells with small nuclei and dense eosinophilic cytoplasm) were counted for silver grains from the photographs and the
average and standard deviation of silver grains for each cell type determined.
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β1-integrin.
Discussion
The role of BPV-1 E7 in the virus life cycle has been an
enigma because the expression of E7 was unconnected to clear
and relevant biological effects and because BPV-1 E7 did not
target retinoblastoma family members as done by oncoproteins
from Papovaviruses and Adenoviruses. BPV-1 E7 lacks an
interaction motif for RB family proteins and has so far failed to
demonstrate a clear in vitro or in vivo interaction with RB or in
vivo activity against RB. Prior studies showed the ability of E7
to augment transformation of rodent fibroblasts by E5 and E6,
but BPV-1 E7 activities in keratinocytes have remained elusive.
In this study we have found an in vivo correlate of BPV-1 E7
activity in keratinocytes.
We demonstrated that BPV-1 E7 expression correlates with
the over-expression of β1-integrin and the aberrant expression
of β1-integrin in suprabasal epithelial cells. Expression of E7
and E5 within virus-induced epitheliomas was highly correlated
to each other and to both over-expressed β1-integrin and PCNA
expression in spinous epithelial cells. This implicates E7 in the
induction of vegetative DNA amplification in spinous layer
epithelial cells. E7 could support the tyrosine phosphorylation
of PYK2, as well as the down-stream activating phosphoryla-tion of ERK. Correlating with the ability of E7 to activate ERK,
both E7 and E5 were able to render EGF-dependent
keratinocytes independent of exogenously added EGF for S
phase entry; while this is a previously reported function for E5
and related to the known effects of E5 upon growth-factor
signaling pathways, this is a new phenotype for E7. Where E5
and E7 differed in our studies was in the ability to promote the
expression of β1-integrin in the absence of exogenously added
EGF; while BPV-1 E7 consistently enhanced the expression of
β1-integrin in the absence of added EGF, E5 had an inconsistent
and lesser effect upon the expression of β1-integrin (Fig. 6B).
β1-integrin is the beta integrin subunit most closely
associated with the regulation of keratinocyte proliferation
and differentiation where it is constitutively paired with α2 and
3 chains. In epithelium, β1-integrin is normally expressed
within basal epithelial cells, where it engages matrix molecules
fibronectin, laminin, and collagen located in the basement
membrane. Several lines of evidence have demonstrated that
β1-integrin has a key role in controlling keratinocyte prolifera-
tion and differentiation. First, the expression level of β1-
integrin is highly correlated with keratinocyte proliferative
potential in vivo; keratinocyte stem cell populations can be
enriched by selection for those cells expressing the highest
levels of β1 integrin (Bata-Csorgo et al., 1993; Jones et al.,
1993). Second, when keratinocytes divide, one daughter cell
remains in contact with the basement membrane as a basal cell,
Fig. 6. The role of EGF and viral oncoproteins E5 and E7 in the expression of
β1-integrin. (A) NIKS keratinocytes transduced with either empty retroviral
vectors or the combination of E5 and E7 expressed from separate retroviral
transductions and independent drug selections were plated onto fibronectin
coated plates without feeder cells as described in Materials and methods. The
indicated cell lines were incubated in media containing 0.5% FCS and either
insulin or EGF as indicated for 48 h prior to lysis in SDS sample buffer and
analysis by western blot with the indicated antibodies. (B) E7 supports β1
integrin expression in the absence of EGF. NIKS cell transduced with either
empty vector, E5, or E7, and were cultured in the presence or absence of added
EGF or insulin as indicated. After 48 h, the cultures were processed for western
blot detection of β1 integrin as described in part A. E7 supports β1 integrin
expression to a greater extent than E5 in the absence of exogenous EGF. (C) E7
protein supports the expression of β1 integrin in the absence of EGF. NIKS cells
retrovirally transduced with the indicated E5, E7, or mutated E7 oncoproteins
were treated as described in part B above and analyzed for β1 integrin
expression by western blot. E7Δ118 is deleted of the second zinc finger of E7.
Mutation of E7 blocks the ability of E7 to support β1 integrin expression in the
absence of EGF.
Fig. 7. E7 and EGF signaling to ERK and PYK2. (A) NIKS keratinocyte
cultures transduced with the indicated retroviruses were prepared as described in
the legend to Fig. 6, lysed in 1% SDS lysis buffer, equalized for protein content,
and analyzed by western blot with the indicated antibodies. Equal amounts of
the remaining samples were neutralized by the addition of NP40 and were
immune precipitated with 4G10 antibody to phosphotyrosine. The immune
precipitates were analyzed by western blot using monoclonal antibody to PYK2
(bottom panel). (B) NIKS keratinocyte cultures were prepared and lysed as
described in part A. Immune precipitates using anti-phosphotyrosine antibody
4G10 were analyzed by western blot in the top panel using antibody to PYK2.
The remaining three panels were from equalized total cell lysates probed with
the indicated antibodies. In the third panel down, the blot was probed
sequentially with monoclonal antibody to phosphorylated activation site of ERK
(clone E10) and JUN kinase, with the location of activated species indicated.
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potential. However, keratinocytes that move into the spinous
layer or keratinocytes deprived of matrix contact in vitro rapidly
lose expression of β1 integrin and enter a terminal differentia-
tion program; terminal differentiation induced by detachment of
keratinocytes from a matrix-coated surface can be repressed by
the addition of signal-stimulating antibodies directed against the
integrins (Green, 1977; Watt et al., 1993). Third, targeted
ablation of β1-integrin in the skin results in profound defects in
basal cell keratinocyte proliferation, hair follicle formation andimpaired wound healing; in addition, these mice also are
defective for the formation of a basement membrane in that
laminin, type IV collagen, and fibronectin are not secreted and
formed into a basement membrane in the absence of β1-integrin
(Brakebusch et al., 2000; Grose et al., 2002; Raghavan et al.,
2000). Fourth, forced transgenic suprabasal expression of β1-
integrin using the involucrin promoter results in focal epithelial
hyperplasia in transgenic mice, indicating that suprabasal
expression of β1-integrin contributes to but is not sufficient
for epithelial hyperplasia (Carroll et al., 1995). Finally, an
activating mutation of β1-integrin has been isolated from a
squamous cancer cell line that alters the responsiveness of
cancer cells to matrix-induced differentiation (Evans et al.,
2003). All of these observations implicate the expression of β1-
integrin as a critical regulatory factor for keratinocyte
proliferation and control of keratinocyte differentiation.
β1-integrin expression is modulated in keratinocytes
responding to wounding and to cytokines associated with the
wounding response. When skin is wounded, there is enhanced
expression of β1 integrin in both basal epithelium and in
Fig. 8. E7 supports S phase entry in the absence of EGF. (A) E7 supports the ability of E7-NIKS cells to enter S phase in the absence of added EGF. NIKS cells were
stably transduced with empty vector, viral oncogenes or mutant oncogenes were grown as described in Materials and methods. After 24 h in the absence of EGF, BrdU
was added to the media for 36 h and the cells were fixed and examined for incorporated BrdU by immune fluorescence. Both E5 and E7 rendered NIKS cells
independent of added EGF, and mutation of E7 abrogated the E7 effect. Shown is the average and standard deviation of three separate experiments. (B) E7-expressing
cells in the spinous layer of fibropapillomas are permissive for DNA synthesis. Co-localization of cells expressing E7 and cells permissive for DNA synthesis were
identified using rabbit antibody to E7 (red) and mouse monoclonal antibody to PCNA (green). PCNA positive cells in the spinous layer also express E7.
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migrate into the wound and persists beyond complete epithelial
closure of the wound (Breitkreutz et al., 1997; Hertle et al.,
1992; Juhasz et al., 1993). Among the integrins shown to be
upregulated and suprabasally expressed during wounding is the
α5 subunit. α5 is also upregulated and suprabasally expressed
in other proliferative pathological conditions such as psoriasis
(Pellegrini et al., 1992). Interestingly, while expression of α5
integrin was prominent in the fibroma portion of the
fibropapilloma, it was not detected in the epithelial portion,
suggesting that bovine epitheliomas are not over expressing
integrins as a marker for a typical proliferative epithelium as
seen after wounding or in psoriasis. Alternatively, the failure to
detect α5 integrin in fibropapilloma epithelium may reflect a
species difference between bovine versus human or rodent
integrin regulation and may reflect differences in inflammationbetween warts and injured or psoriatic epithelium. The role of
both suprabasal integrin expression and persistence of expres-
sion is currently unknown, but may be related to cytoskeletal
changes in epithelial cells that facilitate closure of a wound both
by proliferative and non-proliferative migratory mechanisms. It
is as yet unclear if suprabasal β1-integrin is associated with a
clear signaling pathway as occurs within focal adhesions where
the interactions of integrins with matrix results in the activation
of FAK and c-src, stimulating both survival and proliferative
signals. A suprabasal ligand for β1 integrin has not been
described, but β1 integrin could have scaffolding role or a
signaling ligand could be either associated with the cell surface
or exist in an intracellular compartment.
The ability of BPV-1 E7 to promote β1-integrin expression
is a biochemical marker of BPV-1 E7 action in keratinocytes,
and the first correlated to observations in a productive BPV-1
112 B. Cooper et al. / Virology 355 (2006) 102–114virus infection. Prior studies demonstrated that E7 could
augment transformation of rodent mesenchymal cell lines by
E5 or E6, but this was unconnected to any other measurable
property (Bohl et al., 2001). The mechanism by which E7 may
promote β1-integrin overexpression is the subject of ongoing
experiments. E7 clearly could alter intracellular signaling, since
E7 could supplant the EGF requirement for the tyrosine
phosphorylation of PYK2, phosphorylation of ERK, and DNA
synthesis in NIKS cells. Correlating with these effects, there was
increased β1-integrin RNA in the subpopulation of large
spinous cells in which E5, E7, and β1-integrin protein was
observed. It is also as yet unclear if the induction of β1-integrin
expression is a necessary effector of E7 action or only an
indicator or marker for E7 action. Given the central role of β1-
integrin in keratinocyte proliferation and differentiation, this
distinction may be difficult to resolve. Elucidation of the
mechanism by which BPV-1 E7 acts awaits the complete
identification of cellular interaction partners, the identification
of the functions of those partners, and understanding of how the
interactions with E7 alter their function. While BPV-1 E7 fails to
interact with retinoblastoma family members, a 600 kDa cellular
factor that interacts with both HPV-16 and BPV-1 E7 has been
recently identified and shown to interact with conserved amino
acids at the amino-terminus of both E7 proteins; while binding of
BPV-1 E7 to p600 correlated with E7 enhancement of
transformation by E6, RNAi to p600 reduced anchorage
independent colony formation independent of the expression
of E7 (Demasi et al., 2005; Huh et al., 2005). Preliminary
experiments have shown that HPV-16 E7, which also interacts
with p600, does not promote the expression of β1-integrin in the
absence of exogenous EGF as seen with BPV-1 E7 (data not
shown). As yet the cellular function of p600 and how E7
interaction with this factor may influence transformation
phenotypes remains elusive. The phenotypes elucidated in this
study may be unrelated to transformation of rodent fibroblasts,
which has hitherto been the only phenotype attributable to BPV-
1 E7. However, the ability of BPV-1 E7 to support ERK
activation in keratinocytes is likely to be significant, as
ectopically activated ERK in keratinocytes induces epithelial
hyperplasia in vitro and prevents normal ordered differentiation
of keratinocytes in organotypic cultures (Haase et al., 2001).
The ability BPV-1 E7 to support ERK activation in the
absence of exogenous EGF, support the expression of β1-
integrin, and reduce the EGF requirement of NIKS cells for
DNA synthesis provides additional investigative tools to dissect
the mechanisms of BPV-1 E7 actions.
Materials and methods
Cells and tissue culture
Human NIKS (Normal Immortalized Keratinocytes) cells
were maintained with mouse 3T3 cell mitomycin C treated
feeder cells in F12/DMEM media supplemented with 5% fetal
bovine serum (FBS) as described (Allen-Hoffmann et al., 2000),
and were transduced with replication defective MuLV retro-
viruses expressing BPV-1 E5, BPV-1 E7, and BPV-1 E7mutants. Bovine fibropapillomas were collected from natural
infections and characterized as described (Bohl et al., 2001).
Plasmids
BPV-1 E7 and E7 mutants were cloned in pBabe puro
(Morgenstern and Land, 1990) as previously described (Bohl
et al., 2001). The BPV-1 E5 gene was cloned into pLXSN
as an EcoR1 to BamHI fragment of BPV-1 containing a
translation termination linker interrupting all three reading
frames at nt. 3459; this leaves only the E5 polypeptides
intact.
Antibodies and immune-fluorescence
Two different polyclonal antiserums to BPV-1 E7 have
been previously described in detail (Bohl et al., 2001). Rat
monoclonal antibody to bovine beta1 integrin used for
immune-precipitation (AIIB2) and fluorescence was obtained
from the Developmental Studies Hybridoma Bank at the
University of Iowa, recognizes a conformational epitope of
bovine and human β1 integrin but not mouse or monkey β1
integrin. For western blot detection, the antibody MAb18 (BD
Biosciences) was used that recognizes a denatured epitope that
is broadly species reactive. Other mouse monoclonal anti-
bodies were commercially obtained: PYK2, paxillin, (BD
Biosciences), PCNA and tubulin (Sigma), phosphotyrosine
(clone 4G10, Upstate Biotechnology), phosphospecific anti-
bodies to activated ERK and JUNK (New England Bios-
ciences). Separate rabbit polyclonal antiserums to E5 were the
gifts of Daniel DiMaio (Yale University) and Richard Schlegel
(Georgetown University). All polyclonal antibodies used for
secondary fluorochrome conjugated antibodies as well as
antibodies to viral E5 and E7 proteins were extensively
adsorbed with fixed and denatured cell extract from both
cultured bovine MDBK cells and normal bovine skin to
reduce background binding to bovine tissues. Photomicro-
graphs were taken on a Leica DMLB microscope equipped
with a Spot digital camera and Spot imaging software. Digital
images were adjusted for brightness and contrast with Adobe
Photoshop software.
Western blots
NIKS cells were propagated with mitomycin C treated
feeder fibroblasts. Prior to experiments, feeder cells were
removed by differential trypsinization, and NIKS cells were
plated onto fibronectin-coated tissue culture plastic. One day
later, media was removed and replaced with media supple-
mented with 0.5% FBS, together with insulin and EGF as
indicted in the figures and legends. 48 h later, cells were lysed
in 1% SDS and extracts adjusted for protein concentration.
Equalized amounts of protein were resolved by SDS-PAGE,
transferred to PVDF membranes and blocked with Tris
buffered saline containing 0.05% Tween-20 detergent
(TBST) and 2.5% non-fat dried milk. Western blots were
probed with antibodies and retained antibodies detected with
113B. Cooper et al. / Virology 355 (2006) 102–114secondary goat anti-mouse or anti-rabbit antibodies coupled to
horseradish peroxidase and chemiluminescent detection
(Pierce).
BrdU labeling
Actively growing cultures of NIKS cells were lightly
trypsinized to remove feeder cells and plated without feeder
cells onto fibronectin coated glass coverslips and incubated in
complete media for 24 h. The next day, media was removed
and replaced with media containing 0.5% FBS, insulin, and
either EGF or no EGF as indicated in the figure legends. 24 h
later, BrdU was add to 10 μM and the cells incubated for 36 h
(less than the doubling time of NIKS cells in complete media).
The cells were washed with PBS, fixed in cold methanol and
air-dried. Rehydrated coverslips were acid denatured for 1 h in
2N HCl, and washed sequentially with PBS and PBS with
0.5% triton X-100, then blocked in PBS containing 2.5% BSA
and 0.5% triton X-100 for 2 h and then treated with a 1:100
dilution of antibody to BrdU (Sigma clone BU-33) in blocking
buffer for 2 h. Washed coverslips were stained with DAPI and
Alexa-568-labeled goat-anti-mouse antibody (Molecular
Probes). Three separate photomicrographs of merged images
taken on blue (DAPI) channels and red (BrdU label) were
quantitated for the percent of nuclei that stained positively for
BrdU.
In situ hybridization
Probes for bovine β1-integrin (cloned and sequenced RT-
PCR product corresponding to nts. 1851–2295 of Genbank
AF468058 β1-integrin mRNA), and actin were cloned into
pGEM for the preparation of sense and anti-sense tritiated probes
by in vitro transcription, and hybridized to formalin-fixed and
paraffin-embedded sections of BPV fibropapillomas essentially
as previously described (Stoler, 1990). The in situ hybridization
mixture contained 50% formamide, 0.3 M NaCl, 20 mM Tris–
Cl, 1 mM EDTA, pH 8.0, 1× Denhardt's solution, 500 μg/ml
yeast tRNA and 10% dextran sulfate. Hybridization was carried
out at Tm−25 °C. The final probe concentrations are normalized
for probe lengths, with the shortest probe applied at full
saturation (0.2 μg/ml/kb complexity). Following hybridization,
the specimens were washed at a stringency of Tm—(5–8) °C,
and then overlaid with Kodak NTB-2 autoradiography emul-
sion, exposed for 1–4 weeks at 4 °C, developed photographi-
cally, and lightly stained with hematoxylin and eosin. Probe
length normalization results in number average signals and,
combined with standardized autoradiographic exposure times,
allows direct comparisons of the relative numbers of transcripts
spanning each message. Controls included the use of sense
probes without prior heat denaturation of the DNA as well as
antisense probes.
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